Physician

Megan Bielawski, M.D.

According to 2025 Medicare claims, Megan Bielawski, M.D. (NPI: 1073900080) practices rheumatology in the Akron, OH market, with the plurality of this provider's patient population coming from Summit, OH. This provider's primary affiliated billing organization is CRYSTAL ARTHRITIS CENTER, INC. (NPI: 1841247103; TIN: 202753094) and primary practice location at 44333-2426. Bielawski is affiliated with the IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Bielawski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 403 traditional Medicare patients, billed 103,483 HCPCS/CPT codes, and received $978,872 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,443 prescription claims across 501 beneficiaries totaling $1,219,805 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 153 records totaling $2,483. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,593 to $1,219,805. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$593K$1.2M2020 Medicare payment: $23,448 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,185,834 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $729,762 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $910,565 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $978,872 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202078942$23,448
202132861,615$1,185,834
202230651,490$729,762
202341879,300$910,565
2024403103,483$978,872

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$719K$1.4M2015 Drug cost: $1,593 (USD; Tot_Drug_Cst)2016 Drug cost: $10,555 (USD; Tot_Drug_Cst)2017 Drug cost: $26,646 (USD; Tot_Drug_Cst)2018 Drug cost: $62,828 (USD; Tot_Drug_Cst)2019 Drug cost: $162,106 (USD; Tot_Drug_Cst)2020 Drug cost: $84,182 (USD; Tot_Drug_Cst)2021 Drug cost: $765,801 (USD; Tot_Drug_Cst)2022 Drug cost: $781,359 (USD; Tot_Drug_Cst)2023 Drug cost: $1,437,066 (USD; Tot_Drug_Cst)2024 Drug cost: $1,219,805 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151571$1,593
201658441$10,555
201783744$26,646
201897711$62,828
201977488$162,106
202089434$84,182
20213441,651$765,801
20223411,882$781,359
20234922,494$1,437,066
20245012,443$1,219,805

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more268436$87
36415Insertion of needle into vein for collection of blood sample352608$9
80076Liver function blood test panel274466$8
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count282477$8
82565Blood creatinine level321540$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept391,148$299,290
Humira(Cf) PenAdalimumab27756$271,834
Humira(Cf)Adalimumab12336$143,485
Cimzia (2 Pack)Certolizumab Pegol11448$85,115
ForteoTeriparatide11318$46,245

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.153$2,483ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Megan Bielawski, M.D.?

Tedicare shows public-source Medicare data for Megan Bielawski, M.D. (NPI 1073900080), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Megan Bielawski, M.D. have ACO affiliation data?

Megan Bielawski, M.D. is shown with ACO affiliation data for IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Megan Bielawski, M.D.?

Megan Bielawski, M.D. is linked to CRYSTAL ARTHRITIS CENTER, INC. (billing NPI 1841247103) in the available physician profile data.

Does Megan Bielawski, M.D. have Open Payments data?

Megan Bielawski, M.D. has 153 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.